Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

173
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
173
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

801
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
801
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

294
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
294
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

804
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
804
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

1.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

870
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
870

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mindful diagnostics in culture-negative endocarditis: early noninvasive diagnosis of <i>Tropheryma whipplei</i> by plasma microbial cell-free DNA.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Rethinking flow: the paradox of renoprotection without increased renal blood flow in cardiopulmonary bypass.

Journal of thoracic disease·2026
Same author

Warm ischemic time-dependent effects on oxidative stress, endoplasmic reticulum stress, and inflammation in cold storage human donor hearts.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10.

International journal of molecular sciences·2026
Same author

Management of Dialysis for Patients Receiving Mechanical Circulatory Support.

Journal of the American Society of Nephrology : JASN·2026
Same author

Changes in Vascular Cell Adhesion Molecule-1 in Conventional Versus Robotic Bypass Graft Surgery.

The Journal of surgical research·2026
Same journal

Ultrasensitive Immunoassay Using a Novel Galactose-Deficient IgA1 Antibody and Its Clinical Application in the Diagnosis of IgAN.

Kidney international reports·2026
Same journal

Association of IgG N-Glycans With Adverse Outcomes in CKD.

Kidney international reports·2026
Same journal

Urinary Soluble CD163: A Dynamic Biomarker for Monitoring Treatment Response and Relapse in IgA Nephropathy.

Kidney international reports·2026
Same journal

<i>APOL1</i> Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIV.

Kidney international reports·2026
Same journal

Validation of the Standardized Outcomes in Nephrology - Life Participation (SONG-LP) Instrument in People Receiving Dialysis.

Kidney international reports·2026
Same journal

Effect of Hemodialysis With Citrate on Vascular Calcification.

Kidney international reports·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K

Kidney Function Trajectories With Mechanical Circulatory Support.

Carl P Walther1, Harveen K Lamba2, Ajith P Nair3,4

  • 1Section of Nephrology, Department of Medicine, Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, Texas, USA.

Kidney International Reports
|October 27, 2025
PubMed
Summary
This summary is machine-generated.

Kidney function after left ventricular assist device (LVAD) implantation shows distinct early and late phases. These phases, along with a breakpoint, are linked to patient factors and survival, aiding in understanding adverse kidney outcomes.

Keywords:
LVADeGFRkidneymechanical circulatory supporttrajectory

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.9K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

2.0K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.9K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Area of Science:

  • Cardiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Adverse kidney outcomes are common in left ventricular assist device (LVAD) recipients but poorly understood.
  • Creatinine-based estimated glomerular filtration rate (eGFR) is used to assess kidney function but has uncertain validity and nonlinear changes post-LVAD.

Purpose of the Study:

  • To investigate nonlinear eGFR trajectories within 90 days post-LVAD implantation.
  • To explore relationships between eGFR trajectory parameters, patient factors, and clinical outcomes.

Main Methods:

  • Utilized two cohorts: a single-center (n=190) and a US national (n=10794) LVAD recipient cohort.
  • Employed segmented linear regression with two segments to model eGFR trajectories, comparing it with other models.
  • Assessed associations of trajectory parameters with patient factors and clinical outcomes.

Main Results:

  • Segmented linear regression provided the best fit, identifying early/late slopes, breakpoint time, and breakpoint eGFR.
  • Patient factors like female sex and older age were associated with late trajectory slopes.
  • All four trajectory parameters correlated with survival; breakpoint eGFR and late slope remained significant after adjustment.

Conclusions:

  • Kidney function post-LVAD implantation follows a biphasic trajectory (early/late linear phases with a breakpoint).
  • These trajectory metrics correlate with survival and preimplantation factors.
  • The identified metrics can inform research into adverse kidney outcomes and interventions for LVAD patients.